Clinical trial
Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage…
NCT00449137 · University of Miami, Other · Completed
Key facts
| NCT number | NCT00449137 |
|---|---|
| Title | Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment |
| Official title | A Phase I Study of 5-FU (Plus Leucovorin) and Arsenic Trioxide for Patients With Refractory/Relapsed Metastatic Colorectal Carcinoma |
| Lead sponsor | University of Miami, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Genetic, Other, Procedure |
| Interventions | Arsenic trioxide, Fluorouracil, Leucovorin calcium, Plasma levels of elemental arsenic, Peripheral Blood Mononuclear Cells (PBMC) for mRNA analysis, Tumor Biopsy (Fine-Needle Aspiration) |
| Enrollment | 13 |
| Start date | Jun 1, 2005 |
| Primary completion | Feb 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Mar 19, 2007 |
| Last update posted | Dec 15, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: